drugset / Trial / NCT02936206

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

NCT02936206

RandomizedParallel-groupOpen-labelOther

Summary

The purpose of this study is to microscopically examine breast cancer cells of pre-menopausal and post-menopausal women before and after exposure to one of the two commonly used breast cancer drugs, tamoxifen or fulvestrant.

Timeline

Start
2016-10
Primary completion
2020-05-01
Completion
2020-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Fulvestrant Small molecule 750 mg Intramuscular
Comparator Tamoxifen Small molecule 20 mg Oral

Indications